March 1 – 3, 2018Grand Hyatt Washington

Washington, DC

BC3BREAST CANCERCoordinated CareA N I N T E R D I S C I P L I N A R Y C O N F E R E N C E

www.BC3conference.com

Shawna C. Willey, MD MedStar Regional Breast Health ProgramMedStar Georgetown University Hospital

Washington, DC

David H. Song, MD, MBAMedStar Georgetown University Hospital

Washington, DC

CONFERENCE CHAIRS:

BC3

BREA

ST C

ANC

ERC

oo

rdin

ated

Car

e

Mar

ch 1

– 3

, 201

8 | G

rand

Hya

tt W

ashi

ngto

n | W

ashi

ngto

n, D

C

For m

ore

info

rmat

ion

and

to re

gist

er, p

leas

e vi

sit

ww

w.B

C3c

on

fere

nc

e.c

om

MedS

tar Ge

orgeto

wn U

nivers

ity H

ospit

al30

07 Til

den S

treet,

NW,

Suite

3NWa

shing

ton, D

C 200

08

Learning Objectives

• Recognize the important controversial aspects of coordinated local treatment of breast cancer and breast reconstruction.

• Identify the risks and benefits of prophylactic mastectomy.• Implement surgical techniques designed to improve the likelihood of nipple preservation and reduce the

risk of flap or nipple necrosis with mastectomy. • Recognize the impact of reconstruction on post-mastectomy radiation delivery and, conversely, of the

impact of post-mastectomy radiation on prior reconstruction. • Describe different philosophies regarding radiation delivery including new techniques and how to

minimize side effects to the surrounding tissue. • Describe the risk and benefits of re-staging patients after neoadjuvant chemotherapy.• Describe the pros and cons of downstaging based upon response to chemotherapy pre-mastectomy on

the subsequent treatment plan, the scope and power of oncoplastic surgery in the patient who undergoes breast conservation therapy for breast cancer, and the arguments in favor of a coordinated team approach in oncoplastic surgery to maximize the cosmetic and oncologic outcomes.

• Identify the different methods of breast reconstruction including implant-based reconstruction, flap-based reconstruction, and microsurgical-assisted free flap reconstruction.

• Utilize proper patient selection and timing for breast reconstruction procedures as well as the evolving role of alloplastic materials in breast reconstruction both in terms of enhancing and facilitating device reconstruction of the breast, as well as reconstructing the abdomen after flap harvesting.

• Recognize the disparities that exist with different populations and their respective access to reconstructive surgery.

• Understand the new options available to surgically treat patients with lymphedema.• Recognize the impact that financial toxicity related to the care of breast cancer can have on access to care

and on outcomes.• Appreciate the state-of-the-art techniques in oncoplastic surgery, lymphatic surgery, total alloplastic and

autologous breast reconstruction and the science and techniques behind fat grafting.

Course DescriptionBreast cancer is the most common cancer affecting women. Diagnosis and treatments are part of the practice of a wide number of medical specialists and there are national initiatives calling for a multidisciplinary approach to the care of breast cancer patients. The multiple components and aspects of the treatment of breast cancer require a high level of coordinated care among different specialties. This coordination becomes even more challenging because of the rapid evolution of new treatment modalities and is especially important due to of the possibility of improved outcomes both in terms of curing the disease, as well as maintaining the physical and psychological well-being of the patient.

The meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery and the role of prophylactic mastectomy. Experts in the field will cover the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, and neoadjuvant chemotherapy and its role in restaging breast cancer. Additionally, the program will examine nipple-sparing mastectomy, both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction. It will also cover in depth the state-of-the-art emerging field of lymphatic surgery to treat lymphedema. The latest updates on national trends and data on financial toxicity related to cancer care will also be discussed.

This three-day symposium will evaluate and discuss different models for coordination of breast cancer care from major centers across the United States. The meeting’s intent is not only to educate the faculty and attendees about the wide range of options available for breast cancer coordinated care, but also to encourage the development of more standardized treatment strategies and protocols for the local treatment of breast cancer.

Planning Committee Julia White, MDDirector, Breast Radiation OncologyVice Chair, Radiation OncologyThe Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteProfessor, Radiation OncologyThe Ohio State University College of MedicineColumbus, OH

Anne-Marie Williams, RN, BSN, CBCNRegional Manager, Breast Health ProgramMedStar Georgetown University HospitalWashington, DC

Conference ChairsShawna C. Willey, MDDirector, Regional Breast Health ProgramMedStar HealthMedStar Georgetown University HospitalVice Chairman, Clinical Affairs, SurgeryProfessor, SurgeryGeorgetown University Medical CenterWashington, DC

David H. Song, MD, MBARegional ChiefPlastic and Reconstructive SurgeryMedStar HealthMedStar Georgetown University HospitalChair, Plastic SurgeryGeorgetown University Medical CenterWashington, DC

Target Audience

This program is specifically designed to be a multidisciplinary program and is intended for a wide range of medical practitioners who are interested in the latest information regarding the local treatment of breast cancer. The program is purposely targeted for general, plastic, breast and oncologic surgeons, as well as radiation and medical oncologists. It is also intended for primary care physicians, oncology nurses and practitioners, physical therapists, occupational therapists, genetic counselors, hospital administrators and other members of the healthcare team who have an interest in the treatment of breast cancer patients.

Accreditation

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical

Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 15 Interprofessional Continuing Education (IPCE) credits for learning and change.

For Physical Therapists and Occupational Therapists

Applications for continuing education credits have been made to the Maryland Board of Physical Therapy Examiners and the Maryland Board of Occupational Therapy Practice. To stay up-to-date on the status on continuing education credits, please visit www.BC3conference.com.

Rea

son

s to

Att

end

Net

wo

rk W

ith

E

xper

tsBC

3 is a

uniqu

e opp

ortu

nity

to ha

ve fa

ce-to

-face

time w

ith

expe

rt pr

actit

ioners

, prom

ote

the h

ighes

t stan

dard

for

patie

nt ca

re, an

d disc

uss t

he

value

of a

mult

idisci

plina

ry tea

m ap

proa

ch in

treati

ng

brea

st ca

ncer.

Lear

n F

rom

th

e B

est

Deve

loped

by in

terna

tiona

lly

renow

n fac

ulty,

BC3’s

m

ission

is to

educ

ate

surg

eons

and h

ealth

care

prov

iders

in be

st pr

actic

es

of ca

re us

ing th

e mos

t ad

vanc

ed te

chniq

ues.

Be

Insp

ired

Reign

ite yo

ur en

thus

iasm

by

heari

ng fro

m yo

ur pe

ers

and d

iscus

sing n

ew id

eas

and p

ractic

es in

the w

orld

of br

east

canc

er ca

re.

Vis

it Ic

on

ic

Was

hin

gto

n, D

CTa

ke ad

vant

age o

f the

incom

parab

le co

nferen

ce

venu

e, loc

ated j

ust b

locks

fro

m th

e Whit

e Hou

se,

Was

hingt

on M

onum

ent,

Smith

sonia

n Mus

eum

s, an

d th

e Nati

onal

Mall

.

Continuing Education Credit Information

Res

erve

your

hot

el ro

om b

y Jan

uary

26,

201

8 to

ens

ure

avai

labi

lity a

nd g

roup

rate

s!

www

.face

book

.com

/BC3

conf

eren

ce

w

ww.tw

itter

.com

/BC3

C

Agenda

THURSDAY, MARCH 1, 2018

9:00 AM Registration

11:00 AM Pre-Conference Symposium ThissymposiumisnotcertifiedforCEcredit

1:00 PM Opening Remarks Shawna C. Willey, MD; David H. Song, MD, MBA

SESSION 1: WHAT’S NEW IN BREAST CONSERVATION AND ONCOPLASTIC SURGERY

1:15 PM Optimal Timing For Oncoplastic Reconstruction Albert Losken, MD

1:30 PM Volume Replacement Strategies David H. Song, MD, MBA

1:45 PM The Challenges and Benefits of Oncoplastic Surgery From the Radiation Oncologist’s Perspective Julia White, MD

2:00 PM Fixing the Bad Outcomes Years Later Mark W. Clemens, II, MD

2:15 PM Does Oncoplastic Surgery Improve the Negative Margin Rate? Melvin J. Silverstein, MD

2:30 PM Panel Discussion

3:00 PM Break and Visit the Exhibits

SESSION 2: NIPPLE SPARING MASTECTOMY IN THE COMPLEX PATIENT

3:30 PM Is Nipple Delay Necessary? A Natural Experiment James V. Pellicane, MD

3:45 PM Managing the Positive Nipple Margin After NSM EleniA.Tousimis,MD

4:00 PM Managing Nipple Malposition Troy A. Pittman, MD

4:15 PM Are RT Considerations Different in Pre-pectoral Implants vs. Retro-pectoral Implants? Simona F. Shaitelman, MD

4:30 PM Radiation Before and After NSM Shawna C. Willey, MD

4:45 PM Radiation for Positive DCIS Margins After Mastectomy Julia White, MD

5:00 PM Panel Discussion 5:30 PM Opening Reception with Exhibitors

FRIDAY, MARCH 2, 2018

7:30 AM Registration and Continental Breakfast

8:00 AM Breakfast Symposium ThissymposiumisnotcertifiedforCEcredit

SESSION 3: LYMPHEDEMA

9:00 AM Myths of Lymphedema Sumner A. Slavin, MD

9:15 AM Lymphedema After Treatment for Breast Cancer: A New Approach to an Old Problem Alphonse G. Taghian, MD, PhD

9:30 AM Conservative Treatment of Lymphedema EricM.Wisotzky,MD

9:45 AM Surgical Treatment of Lymphedema Joseph H. Dayan, MD

10:00 AM Panel Discussion

10:30 AM Break and Visit the Exhibits

SESSION 4: SURVIVORSHIP

11:00 AM Post Breast Cancer Treatment Pain Syndromes EricM.Wisotzky,MD

11:15 AM Musculoskeletal Complications From Radiation Therapy and How to Reduce Them JoseG.Bazan,Jr.,MD

11:30 AM Creating a Continuum of Care Pathway EdwardI.Chang,MD

11:45 AM Recurrence Following Reconstruction Can You Keep the Reconstruction? Amy S. Colwell, MD

12:00 PM Psycho-sexual Well-being Jennifer Gass, MD

12:15 PM Panel Discussion

12:30 PM Lunch and Visit the Exhibits

12:45 PM Lunch Symposium ThissymposiumisnotcertifiedforCEcredit

1:45 PM A Tribute to Scott Spear Sumner A. Slavin, MD

SESSION 5: FAT GRAFTING – WHAT’S NEW AND WHAT’S ON THE HORIZON

2:00 PM Primary Fat Grafting in Breast Conservation J. Michael Dixon, MD

2:15 PM Oncologic Ramifications of Fat Grafting JulieE.Park,MD

2:45 PM Fat Grafting as an Adjunct to Reconstruction Troy A. Pittman, MD

3:00 PM Fat Necrosis and Radiation Mylin A. Torres, MD

3:15 PM The Science Behind Fat Grafting EdwardI.Chang,MD

3:30 PM Panel Discussion

3:45 PM Break and Visit the Exhibits

SESSION 6: SPECIAL TOPICS

4:15 PM DIEP Flap Reconstruction After Premastectomy Radiation Therapy Paul Thiruchelvam, MD, PhD

4:30 PM Proton Beam for Breast Cancer Atif J. Khan, MD, MS

4:45 PM ALCL Update Mark W. Clemens, II, MD

5:00 PM Radiation Toxicity Mylin A. Torres, MD

5:15 PM Financial Toxicity of Breast Cancer Care: Who Pays and How Will They Pay? EvanMatros,MD,MPH,MMSc

5:30 PM Update of the ASBrS NSM Registry Shawna C. Willey, MD

5:45 PM Panel Discussion

6:15 PM Abstract Posters and Cocktail Controversies

7:00 PM Evening Symposium ThissymposiumisnotcertifiedforCEcredit

SATURDAY, MARCH 3, 2018

6:30 AM Registration and Continental Breakfast

7:00 AM Breakfast Symposium ThissymposiumisnotcertifiedforCEcredit

SESSION 7: IMPROVING OUTCOMES WITH TECHNOLOGY

8:00 AM ICG Fluorescent Imaging Michael R. Zenn, MD, MBA

8:15 AM Near Infrared Spectroscopy JulieE.Park,MD

8:30 AM Pre-pectoral Implant Placement Troy A. Pittman, MD

8:45 AM AirXpanders Amy S. Colwell, MD

9:00 AM Anything New With ADM? EvanMatros,MD,MPH,MMSc

9:15 AM BioZorb Jennifer Gass, MD

9:30 AM Panel Discussion

10:00 AM Break and Visit the Exhibits

10:30 AM Top Abstract Award and Presentation

SESSION 8: TECHNIQUES

10:45 AM Can the Course of Radiation be Shortened in Patients Who Have Post-mastectomy Immediate Reconstruction? Atif J. Khan, MD, MS

11:00 AM Microsurgical Breast Reconstruction David H. Song, MD, MBA

11:15 AM Direct to Implant Troy A. Pittman, MD

11:30 AM Oncoplastic Reconstruction With IORT Melvin J. Silverstein, MD

11:45 AM Panel Discussion

12:15 PM Closing Remarks

12:30 PM Adjourn

1:00 PM Post-Conference Symposium ThissymposiumisnotcertifiedforCEcredit

Grand Hyatt Washington1000 H Street NWWashington, DC 20001Phone: (202) 582-1234

Room Block Rate: $269/night, plus applicable tax

Please call the Grand Hyatt Washington reservations desk at 202-582-1234 or visit our website at BC3conference.com/hotel-travel to reserve a room at the group rate.

When making reservations by phone, please indicate that you are part of the “Breast Cancer Coordinated Care” group. The cut-off date to book hotel rooms is Friday, January 26, 2018.

Venue Information

FacultyJose G. Bazan, Jr., MDRadiation Oncologist James Comprehensive Cancer CenterThe Ohio State University Columbus, OH

Edward I. Chang, MD Oncologic Plastic SurgeonThe University of Texas MD Anderson Cancer CenterHouston, TX

Mark W. Clemens, II, MDPlastic Surgeon The University of Texas MD Anderson Cancer Center Houston, TX

Amy S. Colwell, MDAssociate Professor Harvard Medical School Massachusetts General Hospital Boston, MA

Joseph H. Dayan, MDCo-Director, Lymphatic Surgery & Research Program Division of Plastic & Reconstructive Surgery Memorial Sloan Kettering Cancer Center New York, NY

J. Michael Dixon, MDConsultant SurgeonClinical DirectorEdinburgh Breast Cancer Now Research GroupWestern General Hospital Edinburgh, UNITED KINGDOM

Jennifer Gass, MDDirector, Breast Fellowship Chief, Surgery Women and Infants Hospital Providence, RI

Atif J. Khan, MD, MSDirector, Breast Cancer Research Associate Attending, Radiation Oncology Memorial Sloan Kettering Cancer Center New York, NY

Albert Losken, MDDirector, Plastic SurgeryEmory HealthcareAtlanta, GA

Evan Matros, MD, MPH, MMScDirector, Microsurgery Fellowship Program Memorial Sloan Kettering Cancer Center New York, NY

Julie E. Park, MDDirector, Breast ReconstructionProgram Director, Plastic and Reconstructive SurgeryThe University of Texas Medical BranchGalveston, TX

James V. Pellicane, MDDirector, Breast Oncology Bon Secours Cancer InstituteRichmond, VA

Troy A. Pittman, MDPlastic and Reconstructive Surgeon Director, Reconstructive Breast Surgery MedStar Georgetown University Hospital Washington, DC

Simona F. Shaitelman, MDMedical Director, Lymphedema Screening Initiative The University of Texas MD Anderson Cancer Center Houston, TX

Melvin J. Silverstein, MDDirector, Hoag Breast Program Gross Endowed Chair, Oncoplastic Surgery Hoag Memorial Hospital PresbyterianNewport Beach, CA

Sumner A. Slavin, MDCo-Director, The Program for Lymphedema Boston Children’s Hospital Boston, MA

Alphonse G. Taghian, MD, PhDDirector, Lymphedema Research Program Department of Radiation OncologyMassachusetts General Hospital Boston, MA

Paul Thiruchelvam, MD, PhDConsultant, Breast Surgeon Imperial College Healthcare London, UNITED KINGDOM

Mylin A. Torres, MDDirector, Glenn Family Breast Center Winship Cancer Institute Emory UniversityAtlanta, GA

Eleni A. Tousimis, MDDirector, Betty Lou Ourisman Breast Health Center Georgetown Lombardi Comprehensive Cancer CenterChief, Breast SurgeryMedStar Georgetown University HospitalWashington, DC

Eric M. Wisotzky, MDChief, Division of Rehabilitation Medicine Director, Cancer RehabilitationMedStar National Rehabilitation HospitalWashington, DC

Michael R. Zenn, MD, MBADirector, Plastic SurgeonZenn Plastic SurgeryRaleigh, NC

  December 2 - February 27 On-Site

Physician $875 $975

Resident/Fellow (proof required) $250 $300

Advanced Practice Clinician $600 $700

Nurse $600 $700

Physical Therapist $600 $700

Occupational Therapist $600 $700

Allied Health Professional $600 $700Industry Professional $900 $1,000

Registration

Online Registration Preferred

Please visit our secure website at BC3conference.com for updated program and registration information. We are unable to accept registrations or cancellations by telephone. If you wish to pay your registration fee by check, please download and print a registration form and mail it to the address on the registration form with your check.

All registrations will be confirmed by email only. Please use an email address that you check regularly. If you have questions regarding registration or do not receive an email confirmation of your registration within 1-2 business days, please contact us at 202-780-1655 orMedStarBC3@gmail.com.

Cancellation Policy

Cancellations made in writing by Friday, January 5, 2018 will be subject to a 50% penalty. No refunds will be given after January 5, 2018. Cancellations will not be accepted by telephone. In the unlikely event that the course is cancelled, MedStar Health will refund the registration fee, but is not responsible for any travel costs.

Please email MedStarBC3@gmail.com or call 202-780-1655 if you have any questions or need any additional information.

Reserve your hotel room by January 26, 2018 to ensure availability and group rates!